JPRN-jRCT1060200019
Recruiting
未知
Clinical and molecular background associated with obinituzumab response in follicular lymphoma
Maeda Yoshinobu0 sites200 target enrollmentOctober 9, 2020
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Maeda Yoshinobu
- Enrollment
- 200
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\) Histologically proven CD20 positive follicular lymphoma (Grade 1, 2, 3A).
- •2\) Age 70\-year\-old or more.
- •3\) Treated by GB therapy as an initial therapy.
- •4\) Written informed consent
Exclusion Criteria
- •Patients who refuse to participate in the study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Molecular and functional analysis of patients with defects of granulocytesD71Functional disorders of polymorphonuclear neutrophilsDRKS00030379Institut für Transfusionsmedizin150
Completed
Not Applicable
Study on Effectiveness and Safety of Intracorporeal Anastomosis in Laparoscopic ColectomyColorectal cancerJPRN-UMIN000050592ational Cancer Center325
Completed
Not Applicable
Study on pathophysiology and clinical features of intractable and rare hepatobiliary and pancreatic disease and prognosis after treatmentpancreaticobiliary maljunctionJPRN-UMIN000042732Osaka City University24
Recruiting
Not Applicable
Clinical aspects and molecular mechanisms in large granular lymphocyte (LGL) leukemia - IDeAL studyblood cancerLarge granular lymphocyte leukemia10024324NL-OMON55452Erasmus MC, Universitair Medisch Centrum Rotterdam150
Not yet recruiting
Phase 2
Study of PCOS and to know the effect of Shatapushpaa Churna and Yoga therapyHealth Condition 1: O992- Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperiumCTRI/2022/03/041365Department of Vikriti Vigyan Faculty of Ayurveda Institute of Medical Sciences BH